Clyde F. Phelix

According to our database, Clyde F. Phelix authored at least 12 papers between 2011 and 2021.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of five.

2021

Structural Insights into the Human Mitochondrial Pyruvate Carrier Complexes.

Liang Xu, Clyde F. Phelix, Liao Y. Chen

J. Chem. Inf. Model., 2021

2017

MSDC-0160 and MSDC-0602 Binding with Human Mitochondrial Pyruvate Carrier (MPC) 1 and 2 Heterodimer: PPARγ Activating and Sparing TZDs as Therapeutics.

Clyde F. Phelix, Allen K. Bourdon, Jason L. Dugan, Greg Villareal, George Perry

Int. J. Knowl. Discov. Bioinform., 2017

Mitochondrial Pyruvate Carrier 1 and 2 Heterodimer, In Silico, Models of Plant and Human Complexes: A Comparison of Structure and Transporter Binding Properties.

Jason L. Dugan, Allen K. Bourdon, Clyde F. Phelix

Int. J. Knowl. Discov. Bioinform., 2017

Alzheimer's and Parkinson's Disease Novel Therapeutic Target: The Mitochondrial Pyruvate Carrier - Ligand Docking to Screen Natural Compounds Related to Classic Inhibitors.

Allen K. Bourdon, Greg Villareal, George Perry, Clyde F. Phelix

Int. J. Knowl. Discov. Bioinform., 2017

Integrating -omics information with biosimulations to assist diagnosis and treatment of diabetes mellitus in silico.

Clyde F. Phelix, Greg Villareal, Richard G. LeBaron, Dawnlee J. Roberson

Proceedings of the 2017 IEEE EMBS International Conference on Biomedical & Health Informatics, 2017

2016

Modeling non-clinical and clinical drug tests in Gaucher disease.

Clyde F. Phelix, Allen K. Bourdon, Greg Villareal, Richard G. LeBaron

Proceedings of the 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 2016

Integrating information on genomics, transcriptomics, proteomics, and metabolomics into biosimulations for individualized personalized medicine.

Clyde F. Phelix, Jason L. Dugan

Proceedings of the 2016 IEEE-EMBS International Conference on Biomedical and Health Informatics, 2016

2015

Low Dose Pioglitazone Attenuates Oxidative Damage in Early Alzheimer's Disease by Binding mitoNEET: Transcriptome-To-Reactome™ Biosimulation of Neurons.

Charles D. Hammack, George Perry, Richard G. LeBaron, Greg Villareal, Clyde F. Phelix

Int. J. Knowl. Discov. Bioinform., 2015

In Silico Biosimulation of Isoflurane Effects on Brain Using Transcriptome-To-Metabolome™ Technology: Anesthesia Effects on Rat Amygdala & Cortex Metabolism.

Allen K. Bourdon, Clyde F. Phelix

Int. J. Knowl. Discov. Bioinform., 2015

2014

Biomarkers from biosimulations: Transcriptome-to-reactome™ Technology for individualized medicine.

Clyde F. Phelix, Greg Villareal, Richard G. LeBaron, Dawnlee J. Roberson

Proceedings of the 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 2014

2011

Transcriptome-To-Metabolome™ Biosimulation Reveals Human Hippocampal Hypometabolism with Age and Alzheimer's Disease.

Clyde F. Phelix, Richard G. LeBaron, Dawnlee J. Roberson, Rosa E. Villanueva, Greg Villareal, Omid B. Rahimi, Sandra Siedlak, Xiongwei Zhu, George Perry

Int. J. Knowl. Discov. Bioinform., 2011

In Vivo and In Silico Evidence: Hippocampal Cholesterol Metabolism Decreases with Aging and Increases with Alzheimers Disease - Modeling Brain Aging and Disease.

Clyde F. Phelix, Richard G. LeBaron, Dawnlee J. Roberson, Rosa E. Villanueva, Greg Villareal, Omid B. Rahimi, Sandra Siedlak, Xiongwei Zhu, George Perry

Proceedings of the Data Mining Workshops (ICDMW), 2011